Trials / Conditions / Recurrent Adrenal Gland Pheochromocytoma
Recurrent Adrenal Gland Pheochromocytoma
3 registered clinical trials studyying Recurrent Adrenal Gland Pheochromocytoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alter NCT04284774 | National Cancer Institute (NCI) | Phase 2 |
| Withdrawn | Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine NCT02831179 | Vanderbilt-Ingram Cancer Center | Phase 1 |
| Terminated | Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraga NCT01340794 | National Cancer Institute (NCI) | Phase 2 |